A LoGiCal® solution for forensic toxicology
Publication date: 16 November 2012
Author: kdm communications limited
Tagged with: Dariusz Zuba, LGC Standards
LGC Standards’ LoGiCal® reference materials are proving a valuable resource for scientists at the Institute of Forensic Research in Krakow, Poland.
LoGiCal reference materials from LGC Standards
Dr Dariusz Zuba, head of the Alcohol and Drug Analysis Laboratory in the Department of Forensic Toxicology, explained: “The Institute is part of the Ministry of Justice and undertakes casework for the courts, as well as carrying out research studies. When we need to purchase reference materials we always contact LGC Standards. The Company’s Polish office is very good at keeping us informed about recent developments and new products.”
“Our standard analytical protocols involve the analysis of samples by both GC-MS and HPLC. In more complex cases, we use LC-QTOFMS. We identify any new materials – legal highs – seized from the market and, if a drug is on the list of controlled substances, we perform quantitative analysis. LoGiCal reference solutions are ideal for this purpose because no preparation is needed, and we have used them to screen for drugs of abuse such as amphetamines and cocaine, as well as for research studies. The solutions are good quality and, unlike powders, are always ready for use; we just dilute them to the appropriate concentration. The uncertainty is also given, which is extremely important. It just makes no sense to buy standards without a Certificate of Analysis.”
To learn more about the LoGiCal product range, visit www.logical-standards.com
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Novartis wins GBCHealth Business Action on Health Award for social ventures initiative (17 May 2013)
- Could a ‘super computer’ help improve epilepsy care? Yes, it’s elementary my dear WATSON (16 May 2013)
- Promising new data demonstrate that a novel pain therapy system manages patients with chronic neuropathic pain (16 May 2013)
- Roche’s obinutuzumab significantly reduced the risk of disease progression or death in people with one of the most common forms of blood cancer (16 May 2013)
- AstraZeneca issues update on accelerated oncology pipeline in advance of 2013 ASCO Annual Meeting (16 May 2013)
Mass Spectrometry: In-depth focus
This free to view Mass Spectrometry in-depth focus features articles from experts at University of British Columbia and University of Colorado Denver.
Stem Cells: In-depth focus
This free to view Stem Cells in-depth focus features articles from experts at Max Planck Institute for Molecular Genetics, Heinrich Heine University and Newcastle University.
Company directory
ABB Analytical Measurements | Analytik Jena AG | Aptalis Pharmaceutical Technologies | ASM - Aerosl-Service AG | Azbil BioVigilant, Inc. | B&W Tek, Inc. | Bio-Optronics, Inc. | bioMérieux | BioTrends – Archilex SA | BMG LABTECH GmbH | Bruker Daltonik GmbH | CAMO Software AS | Catalent Pharma Solutions | Chemical Plant Equipment | Chemspec Europe Ltd | CI Precision | Dow Chemical Company Ltd | DSM Biologics | FOSS NIRSystems, Inc. | GE Analytical Instruments | GenScript USA Inc. | Gerresheimer Group | HACH LANGE GMBH | HAMAMATSU PHOTONICS EUROPE | I Holland Limited | IDBS | IONIMED Analytik GmbH | Lonza | MPI Research | Natoli Engineering Company, Inc. | PANalytical B.V. | Patheon Inc | ReAgent | Roche | Siemens AG | Sirius Analytical Instruments Ltd | TSI | Waters Corporation |
Login to access exclusive content